-Down to Earth India’s public spending on health is among the lowest in South East Asia and BRIC countries The burden of aspirations and expectations seems to be taking a toll on young India, especially males who succumb to suicidal deaths more than their female counterparts, according to the data published by the Central Bureau of Health Intelligence (CBHI). The data showed that over 67 per cent cases of suicidal deaths in...

-The Telegraph New Delhi: A joint study by Indian and Pakistani Doctors has detected abnormally high blood sugar levels in six out of 10 adults in cities, indicating a "frighteningly" higher prevalence of diabetes or its precursor, pre-diabetes, than observed before. The Doctors, who screened 13,720 people aged over 20 in Chennai, Delhi and Karachi, have warned that the high incidence of pre-diabetes suggests millions more urban South Asians are likely to...

-The Times of India NEW DELHI: Despite liberalization of the insurance sector, only around 21.6 crore people - less than one-fifth of India's population - are covered under health insurance. Even among those who have some form of coverage, 67% are covered by public insurance companies, according to National Health Profile 2015, compiled by the Central Bureau of Health Intelligence. The report, which has a separate chapter on health financing, shows despite...

-The Hindu India spends less of its GDP on health than some of the world’s poorest countries’ Every government hospital serves an estimated 61,000 people in India, with one bed for every 1833 people, new official data shows. In undivided Andhra Pradesh, every government hospital serves over 3 lakh patients while in Bihar, there is only one bed for every 8800 people. Union Minister for Health J.P. Nadda released the National Health Profile...

-The Times of India MUMBAI: Certain medicines are being aggressively marketed in India despite inadequate evidence of safety and efficacy, putting patients at risk, said reputed medical journal Lancet. Highlighting weak regulation and monitoring of the domestic drug industry, three recently-introduced medicines are being prescribed and sold though there is a lack of rigorous trials on crucial safety and efficacy parameters. The pharmaceutical industry in India should face the same stringent regulations...